A 62-year-old with COVID-19 (symptom onset 3 days ago) has obesity, CKD stage 3a, and no drug-drug interactions. SpO2 is 96% on room air. Best outpati...

Question

A 62-year-old with COVID-19 (symptom onset 3 days ago) has obesity, CKD stage 3a, and no drug-drug interactions. SpO2 is 96% on room air. Best outpatient therapy to reduce progression risk?

Accepted Answer

Nirmatrelvir-ritonavir for 5 days

Answer

Dexamethasone 6 mg daily for 10 days

Answer

Azithromycin for 5 days

Answer

No antiviral therapy because SpO2 >94%

Answer

Ivermectin

us-abfm MCQ (SBA): COVID-19 (Outpatient)

A 62-year-old with COVID-19 (symptom onset 3 days ago) has obesity, CKD stage 3a, and no drug-drug interactions. SpO2 is 96% on room air. Best outpatient therapy to reduce progression risk?